Advanced search
Publication Cover
Clinical and Experimental Gastroenterology Volume 13, 2020 - Issue
Submit an article Journal homepage
98
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Increases in Autoantibody Level Associated with Degenerative Changes in the Intestinal Mucosa in Liver Cirrhosis

Radmila V Karpova1 Department of Faculty Surgery No.1, University Clinical Hospital No.1, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-0608-9846View further author information
ORCID Icon,
Ksenia S Russkova2 Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2150-7567View further author information
ORCID Icon &
Yuliya N Lavrentieva1 Department of Faculty Surgery No.1, University Clinical Hospital No.1, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaView further author information
Pages 315-320 | Published online: 26 Aug 2020

References

  • Sh ZA, Poletaev AB, Churilov LP. Natural autoantibodies, immunological theories and preventive medicine. Vestnik Saint Petersburg Univ. 2013;11(2):3–16. doi:10.13140/2.1.4460.5440
  • Egea-Valenzuela J, Fernández-Llamas T, García-Marín AV, Alberca-de-las-Parras F, Carballo-Álvarez F. Diagnostic and therapeutic features of small bowel involvement in portal hypertension. Rev Esp Enferm Dig. 2017;109(12):856–862. doi:10.17235/reed.2017.4596/2016
  • Misra V, Dhingra V, Misra SP, Dwivedi M. Colonoscopy in Portal hypertensive colopathy (ed. Miskovitz, P.). Intech Open. 2011;171–176. doi:10.5772/21904
  • Poletaev AB Novye podkhody k rannemu vyyavleniyu patologicheskikh izmenenii v organizme cheloveka in Metodicheskie rekomendacii dlja vrachej. Izd. 2, pererabotannoe i dopolnennoe. (M.: MRC “Immunkulus”; 2011.
  • Chernousov AF, Khorobrykh TV, Karpova RV, Zenkova KI. Effect of cryoprecipitate on liver regeneration in cirrhosis. Novosti Khirurgii. 2017;25(4):350–358. doi:10.18484/2305-0047.2017.4.350
  • Arab JP, Martin-Mateos RM, Shah VH. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. Hepatol Int. 2018;12(1):24–33. doi:10.1007/s12072-017-9798-x
  • Wiest R, Albillos A, Trauner M, Bajaj JS, Jalan R. Targeting the gut-liver axis in liver disease. J Hepatol. 2017;67(5):1084–1103. doi:10.1016/j.jhep.2017.05.007
  • Tripathi A, Debelius J, Brenner DA, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15(7):397–411. doi:10.1038/s41575-018-0011-z
  • Simbrunner B, Mandorfer M, Trauner M, Reiberger T. Gut-liver axis signaling in portal hypertension. World J Gastroenterol. 2019;25(39):5897–5917. doi:10.3748/wjg.v25.i39.5897
  • Daniel B, Reiner W. Gut microbiome and intestinal barrier failure - the “achilles heel” in hepatology? J Hepatol. 2012;56(6):1221–1223. doi:10.1016/j.jhep.2012.03.003
  • De Palma GD, Rega M, Masone S, et al. Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study. Gastrointest Endosc. 2005;62(4):529–534. doi:10.1016/s0016-5107(05)01588-9
  • Urrunaga NH, Rockey DC. Portal hypertensive gastropathy and colopathy. Clin Liver Dis. 2014;18(2):389–406. doi:10.1016/j.cld.2014.01.008
  • Rohini K, Igbinedion SO, Diaz R, Hussain N, Boktor M. Gastrointestinal bleeding secondary to portal hypertensive duodenopathy in a patient with decompensated liver cirrhosis. Case Rep Gastrointest Med. 2018. doi:10.1155/2018/9430701
  • Mekaroonkamol P, Cohen R, Chawla S. Portal hypertensive enteropathy. World J Hepatol. 2015;7(2):127–138. doi:10.4254/wjh.v7.i2.127
  • Guimarães RAP, Perazzo H, Machado L, et al. Prevalence, variability, and outcomes in portal hypertensive colopathy: a study in patients with cirrhosis and paired controls. Gastrointest Endosc. 2015;82(3):469–476. doi:10.1016/j.gie.2015.01.036
  • Kagramanova AV, Yakovenko AV, Balitskiy EV, Gioeva IZ. Portal hypertension colonopathy in patients with hepatic cirrhosis. Clin Morphological Res Sci J. 2010;3:116–119.
  • Gómez-Hurtado I, Such J, Sanz Y, Francés R. Gut microbiota-related complications in cirrhosis. World J Gastroenterol. 2014;20(42):15624–15631. doi:10.3748/wjg.v20.i42.15624
  • Aller MA, de las Heras N, Nava MP, Regadera J, Arias J, Lahera V. Splanchnic-aortic inflammatory axis in experimental portal hypertension. World J Gastroenterol. 2013;19(44):7992–7999. doi:10.3748/wjg.v19.i44.7992
  • Matsushita Y, Narahara Y, Fujimori S, et al. Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension. J Gastroenterol. 2013;48(5):633–639. doi:10.1007/s00535-012-0660-6
  • García-Lezana T, Raurell I, Bravo M, et al. Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis. Hepatology. 2018;67(4):1485–1498. doi:10.1002/hep.29646
  • Kovtun AV, Anikina EV, Jakovenko AV, Gioeva IZ, Jakovenko JP. Microflora of the gastrointestinal tract in the pathogenesis of liver cirrhosis and complications of portal hypertension. Bull Pirogov National Med Surg Cent. 2014;9(4):54–57.
  • Ulyanin AI, Poluektova YA, Pavlov CS, Ivashkin VT. Potential of nutraceutical products for irritable bowel syndrome remission maintenance. J Gastroenterol Hepatol Colorectal. 2018;28(2):101–108. doi:10.22416/1382-4376-2018-28-2-101-108

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.